• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Samsung nets FDA clearance

Article

Samsung nets FDA clearanceKorean PACS vendor Samsung has officially entered the U.S. market, with news that its Raypax PACS product line has received Food and Drug Administration 510(k) clearance. Raypax is based on Windows NT and Windows 98

Samsung nets FDA clearance

Korean PACS vendor Samsung has officially entered the U.S. market, with news that its Raypax PACS product line has received Food and Drug Administration 510(k) clearance. Raypax is based on Windows NT and Windows 98 architecture, although its image server is also available on the Unix platform (

PNN

9/98).

Raypax comprises display software, an image server, a Web server, a film and plain paper printer server, modality interfaces, and a Web-based teleradiology system. Digitizers as well as DICOM and HL7 gateways are available. Samsung also markets a radiology information system.

Samsung, which has U.S. operations in San Jose, CA, plans to install a U.S. beta site for Raypax this month. Raypax is sold through distributors, and Asian sales of Raypax began in April. Beta testing of Raypax was performed at Samsung Medical Center in Seoul.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.